Market Research Assistance

On the Web
Refine Result

By Date

Last Month
Last 3 Months
Last 6 Months
Last Year
Last 2 Years

By Price

< $1000
$1000-$2500
$2501-$4000
$4001-$5500
$5501-$7500
$7501-$9000
>$9000

Anemia Drugs Market Research Reports

Titlepublishedprice

Global Anemia Partnering 2010 to 2017

By Current Partnering
"...... since 2010 report provides understanding and access to partnering deals and agreements entered into by the world's leading healthcare companies. - Trends in partnering deals - Top deals by value - Deals listed by company ......"
01-Mar-2017$1495

Iron Deficiency Anemia - Pipeline Review, H1 2017

By Global Markets Direct
"...... thy red blood cells. Iron helps make red blood cells. When body does not have enough iron, it will make fewer red blood cells or red blood cells that are too small. This is called iron deficiency anemia. Symptoms include feeling grumpy, headaches and......"
28-Feb-2017$2000

Mircera -Drug Insights, 2017

By Delve Insight
"...... des the Mircera sales performance during the historical period and forecast period to 2018. DelveInsight's Report also covers the detailed clinical assessment of Mircera, patents information and exclusivity data, route of synthesis, competitive lands......"
01-Jan-2017$1000

NESP -Drug Insights, 2017

By Delve Insight
"...... ESP sales performance during the historical period and forecast period to 2018. DelveInsight's Report also covers the detailed clinical assessment of NESP, patents information and exclusivity data, route of synthesis, competitive landscape, and gener......"
01-Jan-2017$1000

Iron Deficiency Anemia-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017

By Delve Insight
"...... Anemia Report is to understand the market and pipeline status of the drugs around the Iron Deficiency Anemia to explore the generic development opportunities, licensing opportunities and to gain competitive advantage on designing pipeline startegies......"
01-Jan-2017$2000

Megaloblastic Anemia-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017

By Delve Insight
"...... mia Report is to understand the market and pipeline status of the drugs around the Megaloblastic Anemia to explore the generic development opportunities, licensing opportunities and to gain competitive advantage on designing pipeline startegies. The ......"
01-Jan-2017$2000

Iron Deficiency Anemia-Pipeline Insights, 2017

By Delve Insight
"...... re-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA & EMA......"
01-Jan-2017$1250

Pernicious Anemia-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017

By Delve Insight
"...... port is to understand the market and pipeline status of the drugs around the Pernicious Anemia to explore the generic development opportunities, licensing opportunities and to gain competitive advantage on designing pipeline startegies. The DelveInsi......"
01-Jan-2017$2000

Revlimid -Drug Insights, 2017

By Delve Insight
"...... ovides the Revlimid sales performance during the historical period and forecast period to 2018. DelveInsight's Report also covers the detailed clinical assessment of Revlimid, patents information and exclusivity data, route of synthesis, competitive ......"
01-Jan-2017$1000

Refractory Anemia-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017

By Delve Insight
"...... port is to understand the market and pipeline status of the drugs around the Refractory Anemia to explore the generic development opportunities, licensing opportunities and to gain competitive advantage on designing pipeline startegies. The DelveInsi......"
01-Jan-2017$2000